Gemcitabine and cisplatin followed by chemo-radiation for advanced nasopharyngeal carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 2, 2014, Pages 899-904

  Jamshed, Arif ^a   Hussain, Raza ^a   Iqbal, Hassan ^a  

^a SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL AND RESEARCH CENTRE   (Pakistan)

Author keywords

Concurrent chemo radiotherapy; Induction chemotherapy; Nasopharyngeal cancer

Indexed keywords

ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL; GEMCITABINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CHEMORADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; MORTALITY; NASOPHARYNX CARCINOMA; NASOPHARYNX TUMOR; PATHOLOGY; PROGNOSIS; REMISSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR RECURRENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84894670828     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.2.899     Document Type: Article

References (22)

1. Al-Amro A, Al-Rajhi N, Khafaga Y, et al (2005). Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 62, 508-13.
2. Al-Kourainy K, Kish J, Ensley J, et al (1987). Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer. Cancer, 59, 233-38.
3. Al-Sarraf M (1988). Head and neck cancer: chemotherapy concepts. Semin Oncol, 15, 70-85.
4. Al-Sarraf M, LeBlanc M, Giri PG, et al (1998). Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup Study 0099. J Clin Oncol, 16, 1310-17.
5. Baujat B, Audry H, Bourhis J, et al (2006). Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Bio Phys, 64, 47-56.
6. Bernal AG, Cruz JJ, Sánchez P, et al (1989). Four-day continuous infusion of cisplatin and 5-fluorouracil in head and neck cancer. Cancer, 63, 1927-30.
7. Chitapanarux I, Lorvidhaya V, Kamnerdsupaphon P, et al (2007). Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomized, non-inferiority, open trial. Eur J Cancer, 43, 1399-406.
8. Chan AT, Teo PM, Ngan RK, et al (2002). Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol, 20, 2038-44.
9. Ferlay J, Shin HR, Bray F, et al (2008). 'GLOBOCAN', Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10. Lyon, France: International Agency for Research on Cancer.
10. Langendijk JA, Leemans CR, Buter J, Berkhof J, Slotman BJ (2004). The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol, 22, 4604-12.
11. Li Z, Chong Z, Bijesh G, et al (2010). The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trials. BMC Cancer, 10, 558.
12. Lee AW, Sze WM, Au JS, et al (2005). Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys, 61, 1107-16.
13. Nabell L, Spencer S (2003). Docetaxel with concurrent radiotherapy in head and neck cancer. Semin Oncol, 30, 89-93.
14. Ngan RK, Yiu HH, Lau WH, Yau S, Cheung FY, Chan TM et al (2002). Combination gemcitabine plus cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study. Ann Oncol, 13, 1252-58.
15. Oh JL, Vokes EE, Kies MS, et al (2003). Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer. Ann Oncol, 14, 564-69.
16. Qin D, Hu Y, Yan J, et al (1988). Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer, 61, 1117-24.
17. Sham JST, Choy D (1990). Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. Br J Radio, 63, 51-8.
18. Sankaranarayanan R, Swaminathan R, Brenner H, et al (2010). Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol, 11, 165-73.
19. Wang J, Li J, Hong X, et al (2008). Retrospective case series of gemcitabine and cisplatin in the treatment of recurrent and metastatic nasopharyngeal carcinoma. Oral Oncol, 44, 464-70.
20. Xiayun H, Ou D, Ying H, et al (2012). Experience with combination of cisplatin plus gemcitabine chemotherapy and intensity-modulated radiotherapy for loco-regionally advanced nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol, 269, 1027-33.
21. Yau TK, Lee AWM, Wong DHM, et al (2006). Induction chemotherapy with cisplatin and gemcitabine followed by accelerated radiotherapy and concurrent cisplatin in patients with stage IV (A-B) nasopharyngeal carcinoma. Head Neck, 28, 880-7.
22. Yau TK, Lee AW, Wong DH,et al (2006). Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation: impact of chemotherapy schemes. Int J Radiat Biol Phys, 66, 1004-10.